The Teva Environment
Teva Pharmaceutical Industries Ltd., our parent company, was founded as a wholesale drug business in 1901 in Jerusalem. Teva started building local pharmaceutical plants in Israel in 1930.
After a rich and successful history of acquisitions, mergers and joint ventures, today Teva Pharmaceutical Industries Ltd. is one of the leading pharmaceutical companies in the world, specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals, as well as active pharmaceutical ingredients.
With operations in over 50 countries and approximately 26,000 employees worldwide, the company offers the widest range of cost-effective pharmaceuticals, both generic and branded, to consumers, customers and healthcare providers.
Teva’s Innovative R&D efforts are currently focused on therapies for the central nervous system (with a focus on Multiple Sclerosis), autoimmune diseases and oncology. Teva deploys significant and increasing global reach in IR&D, with initiatives taking place in 27 countries around the world, including 14 Teva R&D sites (Israel, U.S., Canada, Mexico, Argentina, Austria, Belgium, Germany, France, Italy, Netherlands, Spain, U.K., Hungary).
Teva differentiates itself by balancing its portfolio with generic as well as innovative activities, by the strategic depth of its vertical integration, by combining local customer responsiveness with a “global edge,” by its geographic spread and by successfully managing increasing profitable growth and complexity. Backed by over 100 years of experience in the pharmaceutical industry, Teva believes that its success lies in the leadership of their management, the skills and devotion of their people, the quality of their offerings and their focus on customers and patients.
To learn more about the TEVA environment, we invite you to visit Teva Pharmaceutical Industries’ official website.